Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 1:24 pm Sale |
2022-02-11 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WASATCH ADVISORS LP | 312,901 1.200% |
-1,561,001 (-83.30%) |
Filing History |
| 2022-02-11 1:10 pm Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
STATE STREET CORP STT |
1,422,427 5.310% |
-445,693 (-23.86%) |
Filing History |
| 2022-02-10 4:35 pm Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
2,310,059 8.600% |
-274,568 (-10.62%) |
Filing History |
| 2022-02-10 08:22 am Sale |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
The Vanguard Group | 2,751,926 10.270% |
-8,906 (-0.32%) |
Filing History |
| 2022-02-09 6:54 pm Purchase |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,244,747 8.400% |
193,631 (+9.44%) |
Filing History |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BlackRock Inc. BLK |
4,396,721 16.400% |
0 (Unchanged) |
Filing History |
| 2022-01-25 3:03 pm Purchase |
2021-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BlackRock Inc. BLK |
4,396,721 16.400% |
1,245,230 (+39.51%) |
Filing History |
| 2021-10-12 09:29 am Purchase |
2021-09-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
The Vanguard Group | 2,760,832 10.330% |
422,176 (+18.05%) |
Filing History |
| 2021-05-07 3:55 pm Sale |
2021-04-30 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,051,115 7.700% |
-1,220,680 (-37.31%) |
Filing History |
| 2021-02-16 5:30 pm Purchase |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
CARDINAL CAPITAL MANAGEMENT LLC | 1,744,489 6.800% |
269,738 (+18.29%) |
Filing History |
| 2021-02-16 09:34 am Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
STATE STREET CORP STT |
1,868,120 7.250% |
-141,580 (-7.04%) |
Filing History |
| 2021-02-12 10:15 am Purchase |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
Macquarie Group Limited | 1,464,586 5.680% |
1,464,586 (New Position) |
Filing History |
| 2021-02-11 4:42 pm Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
JANUS HENDERSON GROUP PLC JHG |
2,584,628 10.000% |
-376,450 (-12.71%) |
Filing History |
| 2021-02-11 2:54 pm Purchase |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,271,795 12.700% |
233,511 (+7.69%) |
Filing History |
| 2021-02-10 6:16 pm Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
Renaissance Technologies LLC | 0 0.000% |
-1,636,966 (Position Closed) |
Filing History |
| 2021-02-10 11:14 am Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
The Vanguard Group | 2,338,657 9.070% |
-178,074 (-7.08%) |
Filing History |
| 2021-02-09 3:06 pm Purchase |
2021-02-09 | 13G | Ligand Pharmaceuticals Incorporated LGND |
WASATCH ADVISORS LP | 1,873,902 7.300% |
1,873,902 (New Position) |
Filing History |
| 2021-02-08 5:19 pm Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BANK OF AMERICA CORP BAC |
339,280 1.300% |
-1,326,529 (-79.63%) |
Filing History |
| 2021-01-26 6:52 pm Sale |
2020-12-31 | 13G | Ligand Pharmaceuticals Incorporated LGND |
BlackRock Inc. BLK |
3,151,492 12.200% |
-671,917 (-17.57%) |
Filing History |
| 2021-01-15 4:11 pm Unchanged |
2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
LIGAND PHARMACEUTICALS INC LGND |
579 4.100% |
0 (Unchanged) |
Filing History |